Navigation Links
Expandable metal stents used in digestive cancers,,,,

Dr. Todd H. Baron from Mayo Foundation in Rochester, Minnesota has created a break through of sorts by using expandable metal stents in the digestive tract of people afflicted with gastrointestinal cancers.

These patients commonly suffer from obstructions and they present with symptoms like difficulty in swallowing, if the block is in the esophagus; they might present with other symptoms like difficulty in defecation, alternating diarrhea and constipation, bleeding in stools and so on.//

The stents are inserted through an area blocked by cancer and expanded to create a tunnel, and then the metal becomes imbedded in and eventually becomes part of the wall of the organ be it the esophagus, the stomach or the intestines. Dr. Baron said success rates can reach 90%. However the flip side is that severe complications like spread of cancer, bleeding and recurrent blockage can recur.

Upto 2% of patients can die on table from the procedure itself. However Dr. Baron asserts that in most cases of cancerous blockages, the benefit of expandable stents outweigh their risks.

Expandable metal stents have also been used to bypass blockages in the bile ducts, thereby sparing the patient more invasive procedures and long periods of hospitalization, says Dr. Baron in his report published in the May 31st issue of the The New England Journal of Medicine.


'"/>




Page: 1

Related medicine news :

1. Compulsory testing for heavy metal content in herbal medicines
2. High concentration of heavy metals in Herbal medicines
3. Immune response in Occupational metal fume inhaling workers
4. stents Result in allergic reactions
5. Drug-coated heart stents under scrutiny, after study
6. Snake venom a treatment for digestive disease
7. Fructose cause digestive problems
8. Fructose cause digestive problems
9. Infants at lower risk from digestive disease if introduced to cereal early
Post Your Comments:
Breaking Medicine Technology:Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 3Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 4Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 5Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 6Daniel K. Spiegelman Elected to Board of Directors of Omeros 2Shanghai ChemPartner Is Pleased to be Part of Agios' Groundbreaking Cancer Research 2Scientists outline planetary boundaries 3A A safe operating space for humanity 10068 1Scientists outline planetary boundaries 3A A safe operating space for humanity 10068 2Scientists outline planetary boundaries 3A A safe operating space for humanity 10068 3Researchers identify new brain pathway for regulating weight and bone mass 10065 1Researchers identify new brain pathway for regulating weight and bone mass 10065 2McGill garners 19 Canada Research Chairs and more than 2417 million in funding 10062 1McGill garners 19 Canada Research Chairs and more than 2417 million in funding 10062 2McGill garners 19 Canada Research Chairs and more than 2417 million in funding 10062 3